Whalegun
Home

Benjamin Hohl, CFO: Enliven Therapeutics ELVN Sell · Filed 25/02/07

Trade details

Type
Insider sale
Amount
$22,520
Shares · price
1,000 sh · $22.52 a share
Held after
13,000 sh
Stock
Enliven Therapeutics ELVN
Person
Benjamin HohlCFO
Trade date
25/02/05
Filed
25/02/07
Days to filing
2 days

Sold 7.1% of holdings

Share of holding sold
7.1%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/06~25/03/07

Benjamin Hohl's recent trades

  • Benjamin Hohl

    Planned sale10b5-1 planEnliven Therapeutics

    $591.2K

    Filed 09/17

  • Benjamin Hohl

    Sell10b5-1 planEnliven Therapeutics

    $149.2K

    Filed 06/22

  • Benjamin Hohl

    Sell10b5-1 planEnliven Therapeutics

    $59K

    Filed 06/22

  • Benjamin Hohl

    Sell10b5-1 planEnliven Therapeutics

    $55.4K

    Filed 06/22

  • Benjamin Hohl

    Planned sale10b5-1 planEnliven Therapeutics

    $768.2K

    Filed 06/17

Benjamin Hohl, CFO — sold $22.5K of Enliven Therapeutics ELVN · 7.1% of holdings · 10b5-1 plan | Whalegun